cabozantinib,sunitinib
pfizer
['cabozantinib', 'sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabosun']
#cabosun ii: results from a phase 2, open-label, multi-center randomized study of cabozantinib vs sunitinib for non-clear cell #rcc. presentation by andrew johns, md . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology